Date of enactment: April 16, 2014
2013 Senate Bill 251   Date of publication*: April 17, 2014
* Section 991.11, Wisconsin Statutes: Effective date of acts. "Every act and every portion of an act enacted by the legislature over the governor's partial veto which does not expressly prescribe the time when it takes effect shall take effect on the day after its date of publication."
2013 WISCONSIN ACT 294
An Act to create 49.498 (2) (a) 3., 50.045, 450.01 (16) (hm) and 450.033 of the statutes; relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
294,1 Section 1. 49.498 (2) (a) 3. of the statutes is created to read:
49.498 (2) (a) 3. A quality assessment and assurance committee described under subd. 2. may establish written guidelines or procedures for making therapeutic alternate drug selections for the purposes of s. 450.01 (16) (hm) if the committee members include a pharmacist, as defined in s. 450.01 (15).
294,2 Section 2. 50.045 of the statutes is created to read:
50.045 Therapeutic alternate drug selections in nursing homes. (1) A nursing home that does not maintain a quality assessment and assurance committee under s. 49.498 (2) (a) 2. may maintain a committee that consists of the director of nursing services, a physician, as defined in s. 448.01 (5), a pharmacist, as defined in s. 450.01 (15), and at least 2 other members of the nursing home staff.
(2) A committee with the members specified under sub. (1) may establish written guidelines or procedures for making therapeutic alternate drug selections for the purposes of s. 450.01 (16) (hm).
294,3 Section 3. 450.01 (16) (hm) of the statutes is created to read:
450.01 (16) (hm) Making therapeutic alternate drug selections in accordance with written guidelines or procedures previously established by a quality assessment and assurance committee of a nursing facility under s. 49.498 (2) (a) 3. or by a committee established for a nursing home under s. 50.045 (2), if the use of the therapeutic alternate drug selection has been approved for a patient during the period of the patient's stay within the nursing facility or nursing home by any of the following:
1. The patient's personal attending physician.
3. The patient's physician assistant, if the physician assistant is under the supervision of the patient's personal attending physician.
294,4 Section 4. 450.033 of the statutes is created to read:
450.033 Services delegated by physician. A pharmacist may perform any patient care service delegated to the pharmacist by a physician, as defined in s. 448.01 (5).
Loading...
Loading...